- Home
- TCRX vs GDO Comparison
TCRX vs GDO Comparison
Compare TCRX & GDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- GDO
- Stock Information
- Founded
- TCRX 2018
- GDO 2009
- Country
- TCRX United States
- GDO United States
- Employees
- TCRX N/A
- GDO N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- GDO Finance Companies
- Sector
- TCRX Health Care
- GDO Finance
- Exchange
- TCRX Nasdaq
- GDO Nasdaq
- Market Cap
- TCRX 170.1M
- GDO 169.4M
- IPO Year
- TCRX 2021
- GDO N/A
- Fundamental
- Price
- TCRX $2.40
- GDO $11.27
- Analyst Decision
- TCRX Strong Buy
- GDO
- Analyst Count
- TCRX 5
- GDO 0
- Target Price
- TCRX $11.40
- GDO N/A
- AVG Volume (30 Days)
- TCRX 544.4K
- GDO 39.4K
- Earning Date
- TCRX 03-05-2025
- GDO 01-01-0001
- Dividend Yield
- TCRX N/A
- GDO 9.81%
- EPS Growth
- TCRX N/A
- GDO N/A
- EPS
- TCRX N/A
- GDO N/A
- Revenue
- TCRX $9,362,000.00
- GDO N/A
- Revenue This Year
- TCRX N/A
- GDO N/A
- Revenue Next Year
- TCRX $5.14
- GDO N/A
- P/E Ratio
- TCRX N/A
- GDO N/A
- Revenue Growth
- TCRX N/A
- GDO N/A
- 52 Week Low
- TCRX $2.38
- GDO $11.21
- 52 Week High
- TCRX $9.69
- GDO $13.04
- Technical
- Relative Strength Index (RSI)
- TCRX 25.27
- GDO 48.59
- Support Level
- TCRX $2.60
- GDO $10.92
- Resistance Level
- TCRX $2.85
- GDO $11.25
- Average True Range (ATR)
- TCRX 0.17
- GDO 0.12
- MACD
- TCRX 0.00
- GDO 0.03
- Stochastic Oscillator
- TCRX 2.41
- GDO 85.37
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About GDO Western Asset Global Corporate Defined Opportunity Fund Inc.
Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.